These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30867771)

  • 1. Pain prevalence and treatment in patients with metastatic bone disease.
    Vieira C; Fragoso M; Pereira D; Medeiros R
    Oncol Lett; 2019 Mar; 17(3):3362-3370. PubMed ID: 30867771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid Use Among Metastatic Prostate Cancer Patients With Skeletal-related Events.
    Yaldo A; Wen L; Ogbonnaya A; Valderrama A; Kish J; Eaddy M; Kreilick C; Tangirala K; Shields K
    Clin Ther; 2016 Aug; 38(8):1880-9. PubMed ID: 27478111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of enterostomy on analgesic pattern in patients with advanced digestive tract cancer].
    Ling JY; Li YY; Zhong LX; Li WW; Liu H; Cai Y; Hu HB; Zhang JW; Deng YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1159-1164. PubMed ID: 31874532
    [No Abstract]   [Full Text] [Related]  

  • 5. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Improvement in Pain and Functional Outcome but Not Quality of Life After Surgery for Metastatic Long Bone Disease.
    Nooh A; Goulding K; Isler MH; Mottard S; Arteau A; Dion N; Turcotte R
    Clin Orthop Relat Res; 2018 Mar; 476(3):535-545. PubMed ID: 29529637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life after apalutamide treatment in patients with metastatic castration-sensitive prostate cancer (TITAN): a randomised, placebo-controlled, phase 3 study.
    Agarwal N; McQuarrie K; Bjartell A; Chowdhury S; Pereira de Santana Gomes AJ; Chung BH; Özgüroğlu M; Juárez Soto Á; Merseburger AS; Uemura H; Ye D; Given R; Cella D; Basch E; Miladinovic B; Dearden L; Deprince K; Naini V; Lopez-Gitlitz A; Chi KN;
    Lancet Oncol; 2019 Nov; 20(11):1518-1530. PubMed ID: 31578173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study.
    Addison CL; Pond GR; Cochrane B; Zhao H; Chia SK; Levine MN; Clemons M
    J Bone Oncol; 2015 Jun; 4(2):47-53. PubMed ID: 26579488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Scan Index predicts skeletal-related events in patients with metastatic breast cancer.
    Idota A; Sawaki M; Yoshimura A; Hattori M; Inaba Y; Oze I; Kikumori T; Kodera Y; Iwata H
    Springerplus; 2016; 5(1):1095. PubMed ID: 27468396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.
    Chi KN; Protheroe A; Rodríguez-Antolín A; Facchini G; Suttman H; Matsubara N; Ye Z; Keam B; Damião R; Li T; McQuarrie K; Jia B; De Porre P; Martin J; Todd MB; Fizazi K
    Lancet Oncol; 2018 Feb; 19(2):194-206. PubMed ID: 29326030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of ondansetron as an adjunct to lidocaine intravenous regional anesthesia on tourniquet pain and postoperative pain in patients undergoing elective hand surgery: a systematic review protocol.
    Badeaux J; Bonanno L; Au H
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):27-38. PubMed ID: 26447005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric validation of the Brief Pain Inventory-Short Form in patients with systemic lupus erythematosus in the United States.
    Naegeli AN; Tomaszewski EL; Al Sawah S
    Lupus; 2015 Nov; 24(13):1377-83. PubMed ID: 26038345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
    Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
    Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial.
    Basch E; Autio K; Ryan CJ; Mulders P; Shore N; Kheoh T; Fizazi K; Logothetis CJ; Rathkopf D; Smith MR; Mainwaring PN; Hao Y; Griffin T; Li S; Meyers ML; Molina A; Cleeland C
    Lancet Oncol; 2013 Nov; 14(12):1193-9. PubMed ID: 24075621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Social and Functional Implications of High- Versus Low-Dose Opioids on Chronic Non-Cancer Pain.
    Denawa Y; Kurtz W; Conermann T
    Pain Physician; 2019 Jul; 22(4):401-411. PubMed ID: 31337176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of immediate-release opioids as supplemental analgesia during management of moderate-to-severe chronic pain with buprenorphine transdermal system.
    Silverman S; Raffa RB; Cataldo MJ; Kwarcinski M; Ripa SR
    J Pain Res; 2017; 10():1255-1263. PubMed ID: 28579823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents.
    Patrick DL; Cleeland CS; von Moos R; Fallowfield L; Wei R; Öhrling K; Qian Y
    Support Care Cancer; 2015 Apr; 23(4):1157-68. PubMed ID: 25533578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
    Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
    Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.